KVUE

Kenvue Inc.

• TipRanks·1d ago

  RBC Capital Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)

• Simply Wall St·1d ago

  Assessing Kenvue (NYSE:KVUE) Valuation After New Dermatology Data And Product Launches

• NASDAQ·1d ago

  Could Buying This Dividend Pharma Stock Today Set You Up for Life?

• Dow Jones·4d ago

  Kenvue Is Maintained at Neutral by UBS

• Dow Jones·4d ago

  Kenvue Price Target Cut to $18.00/Share From $19.00 by UBS

• Benzinga·4d ago

  UBS Maintains Neutral on Kenvue, Lowers Price Target to $18

• TipRanks·4d ago

  Kenvue Inc call volume above normal and directionally bullish

• Simply Wall St·4d ago

  Kenvue’s Dermatologist-Focused Skincare Push Might Change The Case For Investing In Kenvue (KVUE)

• Simply Wall St·04/03 21:28

  Is It Time To Reassess Kenvue (KVUE) After Its Separation From Johnson & Johnson?

• Simply Wall St·04/02 09:24

  Kenvue (KVUE) Valuation Check After Dermatology Product Launches And Research Push

• Seeking Alpha·04/01 10:22

  Stocks hedge funds love

• NASDAQ·03/30 23:59

  After Hours Most Active for Mar 30, 2026 : NVDA, CMCSA, WBD, C, KVUE, T, VCIT, AAPL, CTSH, PFE, HPE, JPM

• Seeking Alpha·03/29 02:45

  Procter & Gamble, Johnson & Johnson Among 9 Companies To Announce Dividend Increases In The First Half Of April

• Simply Wall St·03/27 15:11

  How Investors May Respond To Kenvue (KVUE) Dermatologist-Focused Skincare Innovation And Sun Protection Push

• Simply Wall St·03/24 20:07

  Evaluating Kenvue (KVUE) After Choppy Trading And Conflicting Signals On Valuation